{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:58:02Z","timestamp":1781308682464,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2016ZX09101120\\u2013004"],"award-info":[{"award-number":["2016ZX09101120\\u2013004"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128443","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T20:00:37Z","timestamp":1773345637000},"page":"128443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Post-marketing surveillance of adverse events following enterovirus type 71 inactivated vaccine in China, 2016\u20132023"],"prefix":"10.1016","volume":"79","author":[{"given":"Keli","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minrui","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhou","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance E.","family":"Rodewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zundong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128443_bb0005","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-6-180","article-title":"Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the first 7 years","volume":"6","author":"Podin","year":"2006","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2026.128443_bb0010","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1086\/314032","article-title":"Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease. For the outbreak study group","volume":"31","author":"Chan","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128443_bb0015","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1348-0421.2002.tb02743.x","article-title":"Outbreak of central nervous system disease associated with hand, foot, and mouth disease in Japan during the summer of 2000: detection and molecular epidemiology of enterovirus 71","volume":"46","author":"Fujimoto","year":"2002","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2026.128443_bb0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3201\/eid1301.020112","article-title":"Epidemic hand, foot and mouth disease caused by human enterovirus 71","volume":"9","author":"Chan","year":"2003","journal-title":"Singapore Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128443_bb0025","first-page":"147","article-title":"Trend of epidemics and variation of pathogens of hand, foot and mouth disease in China: a dynamic series analysis, 2008-2017","volume":"40","author":"Zhang","year":"2019","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128443_bb0030","first-page":"1626","article-title":"Epidemiological characteristics and trend of hand foot and mouth disease deaths in China from 2008 to 2022","volume":"45","author":"Gao","year":"2024","journal-title":"Chin J Epidemiol"},{"key":"10.1016\/j.vaccine.2026.128443_bb0035","article-title":"Immunogenicity and safety of inactivated enterovirus A71 vaccines in children aged 6-35 months in China: a non-inferiority, randomised controlled trial","volume":"16","author":"Li","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.vaccine.2026.128443_bb0045","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy,safety and Immunogenicity of an Enterovirus 71 Vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"N Engl J Med"},{"issue":"9882","key":"10.1016\/j.vaccine.2026.128443_bb0050","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy,safety and immunogenicity of an inactivated alum-adjuvant Enterovirus 71 vaccine in children in China: a multicenter,randomised,double-blind,placebo-controlled,phase 3 trial","volume":"381","author":"Zhu","year":"2013","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128443_bb0055","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An inactivated enterovirus 71 vaccine in healthy children","volume":"370","author":"Li","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128443_bb0060","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1016\/j.vaccine.2015.04.060","article-title":"Surveillance of adverse events following immunization in China: past, present, and future","volume":"33","author":"Dawei","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128443_bb0065","series-title":"National guideline for the surveillance of adverse events following immunization","author":"China Ministry of Health Food and Drug Administration of China","year":"2010"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128443_bb0070","first-page":"299","article-title":"Adverse events following immunization in China, 2016","volume":"24","author":"Disha","year":"2018","journal-title":"Chin J Vaccines Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128443_bb0075","first-page":"299","article-title":"Adverse events following immunization in China, 2017","volume":"26","author":"Keli","year":"2020","journal-title":"Chin J Vaccines Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128443_bb0080","first-page":"363","article-title":"Surveillance of adverse events following immunization in China, 2018","volume":"26","author":"Zhang","year":"2020","journal-title":"Chin J Vaccines Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128443_bb0085","first-page":"438","article-title":"Surveillance of adverse events following immunization in China, 2019","volume":"27","author":"Zhang","year":"2021","journal-title":"Chin J Vaccines Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128443_bb0090","first-page":"208","article-title":"Surveillance of adverse events following immunization in China, 2020","volume":"28","author":"Zhang","year":"2022","journal-title":"Chin J Vaccines Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128443_bb0095","first-page":"470","article-title":"Surveillance of adverse events following immunization in China, 2021-2022","volume":"30","author":"Zhang","year":"2024","journal-title":"Chin J Vaccines Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128443_bb0100","first-page":"121","article-title":"Surveillance of adverse events following immunization in China, 2023","volume":"31","author":"Zhang","year":"2025","journal-title":"Chin J Vaccines Immun"},{"issue":"17","key":"10.1016\/j.vaccine.2026.128443_bb0105","doi-asserted-by":"crossref","first-page":"574","DOI":"10.46234\/ccdcw2025.092","article-title":"Post-marketing surveillance of adverse events following recombinant zoster vaccine - China, 2020-2023","volume":"7","author":"Li","year":"2025","journal-title":"China CDC Wkly."},{"issue":"04","key":"10.1016\/j.vaccine.2026.128443_bb0110","first-page":"561","article-title":"Analysis of the current vaccination situation of inactivated EV71 vaccine in China from 2017 to 2021","volume":"44","author":"Zhang","year":"2023","journal-title":"Chin J Epidemiol"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128443_bb0115","first-page":"384","article-title":"Surveillance results of adverse events following immunization of enterovirus 71 inactvated vaccine in Guangxi,2016\u20132017","volume":"24","author":"Du","year":"2018","journal-title":"Application Prevention Medicine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128443_bb0120","first-page":"69","article-title":"Analysis of data on post-marketing surveillance of suspected adverse event following immunization with inactivated enterovirus 71 vaccine in Liaoning province, China from 2017 to 2019","volume":"34","author":"Chang","year":"2021","journal-title":"Chin J Biol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128443_bb0125","first-page":"471","article-title":"Post-marketing safety surveillance of inactivated enterovirus 71 vaccine in Hubei province,2016\u20132017","volume":"24","author":"Wang","year":"2018","journal-title":"Chin J Vaccines Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128443_bb0130","first-page":"1097","article-title":"Surveillance results of adverse events following immunization of enterovirus 71 inactivated vaccine","volume":"31","author":"Pan","year":"2019","journal-title":"Prev Med"},{"issue":"33","key":"10.1016\/j.vaccine.2026.128443_bb0135","doi-asserted-by":"crossref","first-page":"834","DOI":"10.46234\/ccdcw2024.180","article-title":"Post-marketing surveillance of adverse events following immunization with Haemophilus Influenzae type b conjugate vaccine - China, 2010-2021","volume":"6","author":"Ren","year":"2024","journal-title":"China CDC Wkly"},{"issue":"05","key":"10.1016\/j.vaccine.2026.128443_bb0140","first-page":"578","article-title":"Surveillance of suspected adverse reactions to the 13-valent pneumococcal polysaccharide conjugate vaccine in China from 2017 to 2020","volume":"29","author":"Li","year":"2023","journal-title":"China Vaccine Immuniz"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128443_bb0145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/14760584.2022.2011228","article-title":"No association between enterovirus 71 (EV71) vaccination and risk of febrile seizures: a population-based near real-time surveillance study","volume":"21","author":"Sun","year":"2022","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128443_bb0150","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/all.13732","article-title":"The global incidence and prevalence of anaphylaxis in children in the general population: a systematic review","volume":"74","author":"Wang","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.vaccine.2026.128443_bb0155","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.vaccine.2016.09.024","article-title":"IgA vasculitis (Henoch Schonlein): case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"35","author":"Woerner","year":"2017","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128443_bb0160","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.revmed.2016.12.016","article-title":"Epidemiology and pharmacoepidemiology of immune thrombocytopenia","volume":"28","author":"Moulis","year":"2017","journal-title":"Rev Med Interne"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26002513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26002513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:54:49Z","timestamp":1781308489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26002513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":31,"alternative-id":["S0264410X26002513"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128443","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-marketing surveillance of adverse events following enterovirus type 71 inactivated vaccine in China, 2016\u20132023","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128443"}}